These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19758845)

  • 41. Computational biology in anti-tuberculosis drug discovery.
    Murphy DJ; Brown JR
    Infect Disord Drug Targets; 2009 Jun; 9(3):319-26. PubMed ID: 19519485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.
    Stanley SA; Grant SS; Kawate T; Iwase N; Shimizu M; Wivagg C; Silvis M; Kazyanskaya E; Aquadro J; Golas A; Fitzgerald M; Dai H; Zhang L; Hung DT
    ACS Chem Biol; 2012 Aug; 7(8):1377-84. PubMed ID: 22577943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minding the gaps in tuberculosis research.
    Ekins S; Nuermberger EL; Freundlich JS
    Drug Discov Today; 2014 Sep; 19(9):1279-82. PubMed ID: 24993157
    [No Abstract]   [Full Text] [Related]  

  • 46. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 47. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of the Intracellular Mycobacterium tuberculosis Drug Effect and Prediction of the Clinical Dose-Response Relationship Using Intracellular Pharmacodynamic Modeling (PD
    Donnellan S; Martínez-Rodríguez C; Aljayyoussi G; Biagini GA
    Methods Mol Biol; 2021; 2296():393-408. PubMed ID: 33977461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yeast three-hybrid screening for identifying anti-tuberculosis drug targets.
    Moser S; Johnsson K
    Chembiochem; 2013 Nov; 14(17):2239-42. PubMed ID: 24133019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current challenges in drug discovery for tuberculosis.
    Kumar A; Chettiar S; Parish T
    Expert Opin Drug Discov; 2017 Jan; 12(1):1-4. PubMed ID: 27797593
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural genomics approach to drug discovery for Mycobacterium tuberculosis.
    Ioerger TR; Sacchettini JC
    Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
    Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
    Urban M; Šlachtová V; Brulíková L
    Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach.
    Soto R; Perez-Herran E; Rodriguez B; Duma BM; Cacho-Izquierdo M; Mendoza-Losana A; Lelievre J; Aguirre DB; Ballell L; Cox LR; Alderwick LJ; Besra GS
    Sci Rep; 2018 Aug; 8(1):12664. PubMed ID: 30140040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent Advances in Medicinal Chemistry to Treat Tuberculosis - Part-I.
    Srivastava SK
    Curr Top Med Chem; 2019; 19(8):565-566. PubMed ID: 31210107
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
    Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Progress in role of novel anti-tuberculosis drug targets and their inhibitors].
    Ji L; Xie J
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1326-1337. PubMed ID: 30152218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.